Xianghua Huang

13PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 24, 2026
Comparison of bortezomib with dexamethasone and thalidomide with dexamethasone in the treatment of patients with monoclonal immunoglobulin deposition disease.

|Apr 01, 2026
B -Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor- T -Cell Therapy for Relapsed or Refractory AL Amyloidosis.

Xianghua Huang, Xiaomei Wu, Wencui Chen

|Dec 26, 2025
Bortezomib combined with autologous stem cell transplantation overcomes cytogenetic abnormalities in AL amyloidosis.

Yixuan Ren, Weiwei Xu, Jinzhou Guo

|Jul 17, 2025
Kidney disease after hematopoietic stem cell transplant-treatment standard.

Yu Zhang, Weiwei Fu, Xianghua Huang

|Feb 19, 2025
Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance.

Mengnan Liu, Liang Zhao, Jinzhou Guo

|Dec 19, 2024
Serum free light chain level-based and non-fixed cycle daratumumab treatment strategy for patients with light chain amyloidosis.

Zhen Li, Jinzhou Guo, Wencui Chen

Pageof 3

Frequent Collaborators

1 joint publications

Lijuan Chen

1 joint publications

Yuanyuan Zhang

1 joint publications

Xiaomei Wu

1 joint publications

Wencui Chen